BioGutPro x 60 Vegetable Capsules
Sold by FMI Health
INR 33,328.00
View at FMI Health- Store
- fmihealth.com
- Brand
- Biolongevity Labs
- Product type
- Peptides
- Collected
- 2026-11-20
From the retailer
Description-- BioGutPro - Advanced Gut Barrier and Regenerative Complex
Exploring Intestinal Integrity, Inflammation Modulation, and Tissue Repair
BioGutPro is a next-generation research formulation designed to assist investigators studying gut barrier function, regenerative processes, and localized inflammation. It combines seven complementary bioactive compounds - BPC-157, KPV, N-Acetyl Larazotide, GHK-Cu, CoreBiome® Tributyrin, Sodium Bicarbonate, and Zinc L-Carnosine - to create a synergistic model for exploring mucosal protection and intestinal healing.
Key Components of BioGutPro
- BPC-157 (1000 mcg per serving*) – Studied for its potential to support tissue repair, angiogenesis, and gut lining protection.
- KPV (500 mcg per serving*) – A tripeptide noted for modulating inflammatory responses and supporting immune balance in gut tissue.
- N-Acetyl Larazotide (500 mcg per serving*) – Investigated for its role in reinforcing tight junctions and reducing intestinal permeability.
- GHK-Cu (2 mg per serving*) – A copper-binding peptide that stimulates collagen synthesis and supports tissue regeneration.
- CoreBiome® Tributyrin (400 mg per serving*) – A direct source of butyrate, nourishing colonocytes and promoting mucosal integrity.
- Sodium Bicarbonate (150 mg per serving*) – Functions as a metabolic buffer, supporting optimal pH balance for nutrient absorption.
- Zinc L-Carnosine (100 mg per serving*) – Provides antioxidant and gut-supportive properties, aiding mucosal repair.
*Serving size = 2 capsules
Research Focus Areas
- Gut barrier integrity and tight junction regulation
- Inflammation modulation and cytokine balance
- Tissue regeneration and collagen synthesis
- Nutrient absorption and mucosal nourishment
- Oxidative stress reduction and antioxidant support
Synergistic Potential
Together, BioGutPro’s seven bioactive compounds create a comprehensive research model:
- BPC-157 accelerates cellular repair and regeneration.
- KPV modulates inflammatory signaling.
- N-Acetyl Larazotide strengthens gut barrier function.
- GHK-Cu supports collagen synthesis and tissue remodeling.
- CoreBiome® Tributyrin nourishes colonocytes and balances the microbiome.
- Sodium Bicarbonate maintains optimal gut pH.
- Zinc L-Carnosine reinforces mucosal defense and repair.
This synergy provides a unique opportunity to study gut healing, inflammation modulation, and regenerative processes in preclinical models.
Research
BPC-157 and Gastrointestinal Healing - BPC-157 is a synthetic peptide investigated for its regenerative and anti-inflammatory properties. Research suggests that it supports gastrointestinal repair by promoting angiogenesis and stimulating fibroblast activity. In preclinical models, BPC-157
KPV (Lys-Pro-Val) and Inflammation Modulation - KPV
N-Acetyl Larazotide and Tight Junction Regulation - N-Acetyl Larazotide
GHK-CU and Tissue Regeneration - GHK-CU
CoreBiome® Tributyrin and Colonocyte Energy Supply - CoreBiome® Tributyrin
Sodium Bicarbonate and pH Optimization - Sodium bicarbonate
Zinc L-Carnosine and Mucosal Protection - Zinc L-carnosine
Synergistic Effects in BioGutPro
BioGutPro
- BPC-157
- KPV
- N-Acetyl Larazotide
- GHK-CU
- CoreBiome® Tributyrin
- Sodium Bicarbonate
- Zinc L-Carnosine
Referenced Citations
-
Sikiric P, Seiwerth S, Rucman R, et al. (2018). Stable gastric pentadecapeptide BPC 157: vascular recruitment and therapeutic potential in gastrointestinal tract injuries. Current Pharmaceutical Design, 24(18), 1990–2001.
-
Seiwerth S, Brcic L, Klicek R, et al. (2014). Stable gastric pentadecapeptide BPC 157: an update on the development of a wound-healing agent. Expert Opinion on Biological Therapy, 14(10), 1371–1381.
-
Catania A, Gatti S, Colombo G, Lipton JM. (2004). Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacological Reviews, 56(1), 1–29.
-
Kelly CP, Green PH, Murray JA, et al. (2013). Safety, tolerability, and effects on markers of intestinal permeability of larazotide acetate in celiac disease: a phase I randomized trial. Alimentary Pharmacology & Therapeutics, 38(6), 659–670.
-
Levy C, Zoratti EM, et al. (2021). Larazotide acetate for regulating tight junction integrity: a potential therapy for celiac disease. Gastroenterology & Hepatology, 17(3), 125–134.
-
Pickart L. (2008). The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: a hypothesis. Clinical Interventions in Aging, 3(2), 329–336.
-
McNaughton LR, Siegler J, Midgley A. (2008). Ergogenic effects of sodium bicarbonate. Current Sports Medicine Reports, 7(4), 230–236.
Label--
Molecular Structure and Data
| Compound | Molecular Formula | CAS Number | Molecular Weight |
| BPC-157 | |||
| KPV (Lys-Pro-Val) | |||
| N-Acetyl Larazotide | |||
| GHK-Cu | |||
| CoreBiome® Tributyrin | |||
| Sodium Bicarbonate | |||
| Zinc L-Carnosine |
Dosage--For Research Purposes Only